Low Density Lipoprotein Receptor-related Protein and Factor IXa Share Structural Requirements for Binding to the A3 Domain of Coagulation Factor VIII*

Low-density lipoprotein receptor-related protein (LRP) is an endocytic receptor that binds multiple distinct ligands, including blood coagulation factor VIII (FVIII). FVIII is a heterodimeric multidomain protein that consists of a heavy chain (domains A1, a1, A2, a2, and B) and a light chain (domains a3, A3, C1, and C2). Both chains contribute to high-affinity interaction with LRP. One LRP-interactive region has previously been located in the C2 domain, but its affinity is low in comparison with that of the entire FVIII light chain. We now have compared a variety of FVIII light chain derivatives with the light chain of its homolog FVa for LRP binding. In surface plasmon resonance studies employing LRP cluster II, the FVa and FVIII light chains proved different in that only FVIII displayed high-affinity binding. Because the FVIII a3-A3-C1 fragment was effective in associating with LRP, this region was explored for structural elements that are exposed but not conserved in FV. Competition studies using synthetic peptides suggested that LRP binding involves the FVIII-specific region Lys1804–Ala1834 in the A3 domain. In line with this observation, LRP binding was inhibited by a recombinant antibody fragment that specifically binds to the FVIII sequence Glu1811–Lys1818. The role of this sequence in LRP binding was further tested using a FVIII/FV chimera in which sequence Glu1811–Lys1818 was replaced with the corresponding sequence of FV. Although this chimera still displayed residual binding to LRP cluster II, its affinity was reduced. This suggests that multiple sites in FVIII contribute to high-affinity LRP binding, one of which is the FVIII A3 domain region Glu1811–Lys1818. This suggests that LRP binding to the FVIII A3 domain involves the same structural elements that also contribute to the assembly of FVIII with FIXa.

[1]  Kenneth G. Mann,et al.  Surface-dependent reactions of the vitamin K-dependent enzyme complexes , 1990 .

[2]  G. Bu,et al.  High Affinity Binding of Receptor-associated Protein to Heparin and Low Density Lipoprotein Receptor-related Protein Requires Similar Basic Amino Acid Sequence Motifs* , 2001, The Journal of Biological Chemistry.

[3]  T. Ortel,et al.  Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII. , 2002, Blood.

[4]  J. Voorberg,et al.  Multiple VH genes are used to assemble human antibodies directed toward the A3-C1 domains of factor VIII. , 2001, Blood.

[5]  M. Shima,et al.  Some human inhibitor antibodies interfere with factor VIII binding to factor IX. , 1998, Blood.

[6]  G. Vehar,et al.  Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. , 1986, Biochemistry.

[7]  P. Lollar,et al.  Association of the factor VIII light chain with von Willebrand factor. , 1988, The Journal of biological chemistry.

[8]  A. Goodall,et al.  Purification of human factor VIII:C and its characterization by Western blotting using monoclonal antibodies. , 1985, Biochemistry.

[9]  K. Mann,et al.  Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Pannekoek,et al.  Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor , 1998 .

[11]  S. Bajaj,et al.  Factor IXa:Factor VIIIa Interaction , 2001, The Journal of Biological Chemistry.

[12]  P. Lollar,et al.  Activation of porcine factor VIII:C by thrombin and factor Xa. , 1985, Biochemistry.

[13]  W. Ouwehand,et al.  Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes. , 2000, Blood.

[14]  P. Lenting,et al.  Interaction between factor VIII and LDL receptor-related protein. Modulation of coagulation? , 2000, Trends in cardiovascular medicine.

[15]  J. T. ten Cate,et al.  The missense mutation Arg593 --> Cys is related to antibody formation in a patient with mild hemophilia A. , 1997, Blood.

[16]  M. Brown,et al.  39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. , 1991, The Journal of biological chemistry.

[17]  S. Moestrup,et al.  Identification of Residues in α-Macroglobulins Important for Binding to the α2-Macroglobulin Receptor/Low Density Lipoprotein Receptor-related Protein* , 1996, The Journal of Biological Chemistry.

[18]  S. Pizzo,et al.  Selective Mutations in Cloned and Expressed α-Macroglobulin Receptor Binding Fragment Alter Binding to Either the α2-Macroglobulin Signaling Receptor or the Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor* , 1996, The Journal of Biological Chemistry.

[19]  R. Houghten General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Keyt,et al.  Structure of human factor VIII , 1984, Nature.

[21]  P. Lenting,et al.  The life cycle of coagulation factor VIII in view of its structure and function. , 1998, Blood.

[22]  P. Fay,et al.  Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit. , 1991, The Journal of biological chemistry.

[23]  K. Orth,et al.  Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein. , 1994, The Journal of biological chemistry.

[24]  G. E. Gilbert,et al.  Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site. , 1995, Blood.

[25]  M. Verbeet,et al.  Biological activity of recombinant factor VIII variants lacking the central B‐domain and the heavy‐chain sequence Lys713‐Arg740: discordant in vitro and in vivo activity , 1993, British journal of haematology.

[26]  P. Lenting,et al.  Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII. , 1994, The Journal of biological chemistry.

[27]  P. Lenting,et al.  Factor VIII-Factor IX Interactions: Molecular Sites Involved in Enzyme-Cofactor Complex Assembly , 1999, Thrombosis and Haemostasis.

[28]  B. Binder,et al.  Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice. , 2000, Blood.

[29]  J. V. van Mourik,et al.  The Light Chain of Factor VIII Comprises a Binding Site for Low Density Lipoprotein Receptor-related Protein* , 1999, The Journal of Biological Chemistry.

[30]  H. Griffin,et al.  PCR Technology : Current Innovations , 1994 .

[31]  S. Moestrup,et al.  Alpha 2-macroglobulin-proteinase complexes, plasminogen activator inhibitor type-1-plasminogen activator complexes, and receptor-associated protein bind to a region of the alpha 2-macroglobulin receptor containing a cluster of eight complement-type repeats. , 1993, The Journal of biological chemistry.

[32]  I. Mikhailenko,et al.  Recognition of α2-Macroglobulin by the Low Density Lipoprotein Receptor-related Protein Requires the Cooperation of Two Ligand Binding Cluster Regions* , 2001, The Journal of Biological Chemistry.

[33]  M. Waknitz,et al.  Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans. , 1993, The Journal of biological chemistry.

[34]  J. V. van Mourik,et al.  Inhibition of human coagulation factor VIII by monoclonal antibodies. Mapping of functional epitopes with the use of recombinant factor VIII fragments. , 1989, The Biochemical journal.

[35]  B. Villoutreix,et al.  3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography. , 2002, Blood.

[36]  I. Mikhailenko,et al.  Role of the Low Density Lipoprotein-related Protein Receptor in Mediation of Factor VIII Catabolism* , 1999, The Journal of Biological Chemistry.

[37]  J. Healey,et al.  Residues 484-508 Contain a Major Determinant of the Inhibitory Epitope in the A2 Domain of Human Factor VIII (*) , 1995, The Journal of Biological Chemistry.

[38]  J. T. ten Cate,et al.  A human alloantibody interferes with binding of factor IXa to the factor VIII light chain. , 1998, Blood.

[39]  P. Fay,et al.  Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site. , 1994, The Journal of biological chemistry.

[40]  A. V. van Zonneveld,et al.  The Second and Fourth Cluster of Class A Cysteine-rich Repeats of the Low Density Lipoprotein Receptor-related Protein Share Ligand-binding Properties* , 1999, The Journal of Biological Chemistry.

[41]  M. S. Brown,et al.  Proteolytic processing of the 600 kd low density lipoprotein receptor‐related protein (LRP) occurs in a trans‐Golgi compartment. , 1990, The EMBO journal.

[42]  P. Fay,et al.  Human Inhibitor Antibodies Specific for the Factor VIII A2 Domain Disrupt the Interaction between the Subunit and Factor IXa* , 1999, The Journal of Biological Chemistry.

[43]  S. Moestrup,et al.  Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors. , 1991, The Journal of biological chemistry.

[44]  P. Lenting,et al.  The Sequence GluLys of Human Blood Coagulation Factor VIII Comprises a Binding Site for Activated Factor IX (*) , 1996, The Journal of Biological Chemistry.

[45]  P. Lenting,et al.  The Role of Cleavage of the Light Chain at Positions Arg1689 or Arg1721 in Subunit Interaction and Activation of Human Blood Coagulation Factor VIII (*) , 1995, The Journal of Biological Chemistry.

[46]  S. Moestrup,et al.  Distribution of the α2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues , 1992, Cell and Tissue Research.

[47]  A. Dorner,et al.  Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. , 1988, The Journal of biological chemistry.

[48]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[49]  P. Lenting,et al.  Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor-related protein. , 2000, Blood.